. .. Nanoparticules-de-tio2,

. .. Ib106,

, Analyse par microfaisceaux d'ions (ou « ion beam analysis » -IBA)

.. .. Questions,

. .. Résultats-expérimentaux,

. Discussion and . .. Perspectives,

. .. Conclusion,

. .. Manuscrit,

, La mise en place de façon parallèle d'une méthode d'analyse à haut débit de voies moléculaires d'intérêt, afin de préparer le terrain d'éventuels tests diagnostiques

. La-plateforme-bmyscreen, cellule de transfert située à l'Institut Bergonié

, NPs de TiO2. L'analyse portait notamment sur la voie du stress du Réticulum Endoplasmique (ATF4, ATF6, ERSE)

, Comme mis en évidence précédemment, l'exposition d'IB115

M. Durante and J. S. Loeffler, Charged particles in radiation oncology, Nat. Rev. Clin

, Oncol, vol.7, pp.37-43, 2010.

S. L. Mcgovern and A. Mahajan, Progress in Radiotherapy for Pediatric Sarcomas

, Oncol. Rep, vol.14, pp.320-326, 2012.

T. F. Delaney and R. L. Haas, Innovative radiotherapy of sarcoma: Proton beam radiation, Eur. J. Cancer, vol.62, pp.112-123, 2016.

R. Serduc, Brain tumor vessel response to synchrotron microbeam radiation therapy: a short-term in vivo study, Phys. Med. Biol, vol.53, pp.3609-3622, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00381397

A. Bouchet, R. Serduc, J. A. Laissue, and V. Djonov, Effects of microbeam radiation therapy on normal and tumoral blood vessels, Phys. Medica, vol.31, pp.634-641, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01236168

F. A. Dilmanian and A. G. Meek, Heavy ion therapy with microbeams, 2010.

X. Zhang, Therapy-Resistant Cancer Stem Cells Have Differing Sensitivity to Photon versus Proton Beam Radiation, J. Thorac. Oncol, vol.8, pp.1484-1491, 2013.

Z. Nikitaki, Systemic mechanisms and effects of ionizing radiation: A new 'old' paradigm of how the bystanders and distant can become the players, Semin. Cancer Biol, pp.77-95, 2016.

J. Barretina, Subtype-specific genomic alterations define new targets for softtissue sarcoma therapy, Nat. Genet, vol.42, pp.715-721, 2010.

A. Tesei, In vitro irradiation system for radiobiological experiments

, Oncol, vol.8, p.257, 2013.

S. Bourret, Fluorescence time-lapse imaging of single cells targeted with a focused scanning charged-particle microbeam, Nucl. Instruments Methods Phys. Res. Sect. B Beam Interact. with Mater. Atoms, vol.325, pp.27-34, 2014.
URL : https://hal.archives-ouvertes.fr/in2p3-00956455

S. Agostinelli, GEANT4 -A simulation toolkit, Nucl. Instruments Methods Phys
URL : https://hal.archives-ouvertes.fr/in2p3-00020246

, Res. Sect. A Accel. Spectrometers, Detect. Assoc. Equip, vol.506, pp.250-303, 2003.

W. Rhomberg, The Radiation Response of Sarcomas by Histologic Subtypes: A Review With Special Emphasis Given to Results Achieved With Razoxane, Sarcoma, pp.1-9, 2006.

K. S. Kim, Radiation-Induced Sarcoma: A 15-Year Experience in a Single Large Tertiary Referral Center, Cancer Res. Treat, vol.48, pp.650-657, 2016.

A. Berrington-de-gonzalez, A. Kutsenko, and P. Rajaraman, Sarcoma risk after radiation exposure, Clin. Sarcoma Res, vol.2, p.18, 2012.

J. N. Cormier and R. E. Pollock, Soft Tissue Sarcomas. CA, Cancer J. Clin, vol.54, pp.94-109, 2004.

T. O. Nielsen and R. B. West, Translating gene expression into clinical care: Sarcomas as a paradigm, J. Clin. Oncol, vol.28, pp.1796-1805, 2010.

F. Chibon, Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity, Nat. Med, vol.16, pp.781-787, 2010.

B. S. Taylor, Advances in sarcoma genomics and new therapeutic targets, Nat. Rev. Cancer, vol.11, pp.541-57, 2011.

F. Chibon, Cancer gene expression signatures-The rise and fall?, Eur. J. Cancer, vol.49, 2000.

A. Italiano, Genetic Profiling Identifies Two Classes of Soft-Tissue Leiomyosarcomas with Distinct Clinical Characteristics, Clin. Cancer Res, vol.19, pp.1190-1196, 2013.

J. R. Williams, Overview of Radiosensitivity of Human Tumor Cells to Low-Dose-Rate Irradiation, Int. J. Radiat. Oncol, vol.72, pp.909-917, 2008.

W. Y. Mansour, T. Rhein, and J. Dahm-daphi, The alternative end-joining pathway for repair of DNA double-strand breaks requires PARP1 but is not dependent upon microhomologies, Nucleic Acids Res, vol.38, pp.6065-6077, 2010.

J. Constanzo, Radiograaff, a proton irradiation facility for radiobiological studies at a 4 MV Van de Graaff accelerator, Nucl. Instruments Methods Phys. Res. Sect. B Beam Interact. with Mater. Atoms, vol.334, pp.52-58, 2014.
URL : https://hal.archives-ouvertes.fr/hal-00830926

A. Munshi, M. Hobbs, and R. E. Meyn, Chemosensitivity, vol.110, pp.21-028, 2005.

N. A. Franken, H. M. Rodermond, J. Stap, J. Haveman, and C. Van-bree, Clonogenic assay of cells in vitro, Nat. Protoc, vol.1, pp.2315-2319, 2006.

B. Pauwels, Comparison of the sulforhodamine B assay and the clonogenic assay for in vitro chemoradiation studies, Cancer Chemother. Pharmacol, vol.51, pp.221-226, 2003.

K. Buch, Determination of cell survival after irradiation via clonogenic assay versus multiple MTT Assay -A comparative study, Radiat. Oncol, vol.7, p.1, 2012.

M. Luttjeboer, Strategies for the analysis of in vitro radiation sensitivity and prediction of interaction with potential radiation modifying agents, Int. J. Radiat. Biol, vol.86, pp.458-66, 2010.

Q. A. Quick and D. A. Gewirtz, Enhancement of radiation sensitivity, delay of proliferative recovery after radiation and abrogation of MAPK (p44/42) signaling by imatinib in glioblastoma cells, Int. J. Oncol, vol.29, pp.407-419, 2006.

S. V. Costes, I. Chiolo, J. M. Pluth, M. H. Barcellos-hoff, and B. Jakob, Spatiotemporal characterization of ionizing radiation induced DNA damage foci and their relation to chromatin organization, Mutat. Res. Mutat. Res, vol.704, pp.78-87, 2010.

A. E. Kiltie, A correlation between residual DNA double-strand breaks and clonogenic measurements of radiosensitivity in fibroblasts from preradiotherapy cervix cancer patients, Int. J. Radiat. Oncol, vol.39, pp.1137-1144, 1997.

K. Rothkamm, I. Kruger, L. H. Thompson, and M. Lobrich, Pathways of DNA Double-Strand Break Repair during the Mammalian Cell Cycle, Mol. Cell. Biol, vol.23, pp.5706-5715, 2003.

I. L. Ibañez, Induction and Rejoining of DNA Double Strand Breaks Assessed by H2AX Phosphorylation in Melanoma Cells Irradiated with Proton and Lithium Beams, Int. J. Radiat. Oncol. Biol. Phys, vol.74, pp.1226-1235, 2009.

V. Calugaru, Involvement of the Artemis Protein in the Relative Biological Efficiency Observed With the 76-MeV Proton Beam Used at the Institut Curie Proton Therapy Center in Orsay, Int. J. Radiat. Oncol, vol.90, pp.36-43, 2014.

P. L. Olive and J. P. Banáth, Phosphorylation of histone H2AX as a measure of radiosensitivity, Int. J. Radiat. Oncol, vol.58, pp.331-335, 2004.

J. P. Banath, Radiation Sensitivity, H2AX Phosphorylation, and Kinetics of Repair of DNA Strand Breaks in Irradiated Cervical Cancer Cell Lines, Cancer Res, vol.64, pp.7144-7149, 2004.

F. Gobet, Experimental and Monte Carlo absolute characterization of a medical electron beam using a magnetic spectrometer, Radiat. Meas, vol.86, pp.16-23, 2016.
URL : https://hal.archives-ouvertes.fr/in2p3-01286932

P. Barberet, Monte-Carlo dosimetry on a realistic cell monolayer geometry exposed to alpha particles, Phys. Med. Biol, vol.57, pp.2189-2207, 2012.
URL : https://hal.archives-ouvertes.fr/in2p3-00695637

J. Pomp, Cell density dependent plating efficiency affects outcome and interpretation of colony forming assays, Radiother. Oncol, vol.40, pp.121-125, 1996.

J. Petrini, The cellular response to DNA double-strand breaks: defining the sensors and mediators, Trends Cell Biol, vol.13, pp.458-462, 2003.

S. Burma, ATM Phosphorylates Histone H2AX in Response to DNA Double-strand Breaks, J. Biol. Chem, vol.276, pp.42462-42467, 2001.

C. J. Bakkenist and M. B. Kastan, DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation, Nature, vol.421, pp.499-506, 2003.

S. Costes, Imaging features that discriminate between foci induced by high-and low-LET radiation in human fibroblasts, Radiat. Res, vol.165, pp.505-515, 2006.

T. J. Reitsema, J. P. Banáth, S. H. Macphail, and P. L. Olive, Hypertonic saline enhances expression of phosphorylated histone H2AX after irradiation, Radiat. Res, vol.161, pp.402-408, 2004.

J. R. Williams, Y. Zhang, J. Russell, C. Koch, and J. B. Little, Human tumor cells segregate into radiosensitivity groups that associate with ATM and TP53 status, Acta Oncol. (Madr), vol.46, pp.628-638, 2007.

A. Lavaf, J. Kao, and S. Peters, ATM Phosphorylation Kinetics as a Biological Reporter of Cellular Radiosensitivity, Int. J. Radiat. Oncol, vol.69, pp.65-66, 2007.

K. J. Mcmanus and M. J. Hendzel, ATM-dependent DNA Damage-independent Mitotic Phosphorylation of H2AX in Normally Growing Mammalian Cells, Mol. Biol. Cell, vol.16, pp.5013-5025, 2005.

J. P. Grutters, Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: A meta-analysis, Radiother. Oncol, vol.95, pp.32-40, 2010.

L. M. Green, Response of Thyroid Follicular Cells to Gamma Irradiation Compared to Proton Irradiation. I. Initial Characterization of DNA Damage, Micronucleus Formation, Apoptosis, Cell Survival, and Cell Cycle Phase Redistribution, Radiat. Res, vol.155, pp.32-42, 2001.

K. M. Prise and G. Schettino, Microbeams in radiation biology: review and critical comparison, Radiat. Prot. Dosimetry, vol.143, pp.335-339, 2011.

O. Zlobinskaya, Reduced side effects by proton microchannel radiotherapy: study in a human skin model, Radiat. Environ. Biophys, vol.52, pp.123-133, 2013.

S. Girst, Subdiffusion supports joining of correct ends during repair of DNA double-strand breaks, Sci. Rep, vol.3, p.2511, 2013.

T. E. Schmid, Low LET protons focused to submicrometer shows enhanced radiobiological effectiveness, Phys. Med. Biol, vol.57, pp.5889-5907, 2012.

N. Taneja, Histone H2AX Phosphorylation as a Predictor of Radiosensitivity and Target for Radiotherapy, J. Biol. Chem, vol.279, pp.2273-2280, 2004.

A. A. Goodarzi and P. A. Jeggo, Irradiation induced foci (IRIF) as a biomarker for radiosensitivity, Mutat. Res. Mol. Mech. Mutagen, vol.736, pp.39-47, 2012.

T. M. Pawlik and K. Keyomarsi, Role of cell cycle in mediating sensitivity to radiotherapy, Int. J. Radiat. Oncol, vol.59, pp.928-942, 2004.

B. T. Bennett, J. Bewersdorf, and K. L. Knight, Immunofluorescence imaging of DNA damage response proteins: Optimizing protocols for super-resolution microscopy, Methods, vol.48, pp.63-71, 2009.

J. Bernier, E. J. Hall, and A. Giaccia, Radiation oncology: a century of achievements

, Nat. Rev. Cancer, vol.4, pp.737-747, 2004.

N. Foray, Victor Despeignes, the Forgotten Pioneer of Radiation Oncology, Int. J. Radiat. Oncol. Biol. Phys, vol.96, pp.717-721, 2016.

K. J. Harrington, Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers, Br. J. Cancer, vol.105, pp.628-639, 2011.

G. Delaney, S. Jacob, C. Featherstone, and M. Barton, The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines, Cancer, vol.104, pp.1129-1137, 2005.

J. E. Scaife, Exploiting biological and physical determinants of radiotherapy toxicity to individualize treatment, Br. J. Radiol, vol.88, p.20150172, 2015.

S. S. Ahmad, S. Duke, R. Jena, M. V. Williams, and N. G. Burnet, Advances in radiotherapy, BMJ, vol.345, p.7765, 2012.

O. U. Ataman, The clinical development of molecularly targeted agents in combination with radiation therapy: a pharmaceutical perspective, Int. J. Radiat. Oncol. Biol. Phys, vol.84, pp.447-454, 2012.

K. Yamoah, T. N. Showalter, and N. Ohri, Radiation Therapy Intensification for Solid Tumors: A Systematic Review of Randomized Trials, Int. J. Radiat. Oncol. Biol. Phys, vol.93, pp.737-745, 2015.

J. J. Kim and I. F. Tannock, Repopulation of cancer cells during therapy: an important cause of treatment failure, Nat. Rev. Cancer, vol.5, pp.516-525, 2005.

A. C. Begg, F. A. Stewart, and C. Vens, Strategies to improve radiotherapy with targeted drugs, Nat. Rev. Cancer, vol.11, pp.239-253, 2011.

M. Orth, Current concepts in clinical radiation oncology, Radiat. Environ. Biophys, vol.53, pp.1-29, 2014.

K. Nakamura, Recent advances in radiation oncology: intensity-modulated radiotherapy, a clinical perspective, Int. J. Clin. Oncol, vol.19, pp.564-569, 2014.

B. Y. Kim, J. T. Rutka, and W. C. Chan, Nanomedicine. N. Engl. J. Med, vol.363, pp.2434-2443, 2010.

A. Z. Wang and J. E. Tepper, Nanotechnology in radiation oncology, J. Clin. Oncol. Off

, J. Am. Soc. Clin. Oncol, vol.32, pp.2879-2885, 2014.

R. B. King, An overview of current practice in external beam radiation oncology with consideration to potential benefits and challenges for nanotechnology, Search of: nanoparticles radiotherapy | Cancer -List Results -ClinicalTrials.gov. Available at, vol.8, p.27, 2017.

E. J. Hall and A. J. Giaccia, Radiobiology for the Radiologist, 2006.

W. Kluwer--perez, &. Brady, and &. , Principles and Practice of Radiation Oncology, vol.19, p.23, 2018.

J. E. Martin, Physics for Radiation Protection, 2013.

, Cancer Nanotechnology: Principles and Applications in Radiation Oncology, vol.22, 2013.

. Applications, , p.30, 2018.

L. Cui, Radiosensitization by gold nanoparticles: Will they ever make it to the clinic?, Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol, vol.124, pp.344-356, 2017.

S. Her, D. A. Jaffray, and C. Allen, Gold nanoparticles for applications in cancer radiotherapy: Mechanisms and recent advancements, Adv. Drug Deliv. Rev, vol.109, pp.84-101, 2017.

S. J. Mcmahon, Biological consequences of nanoscale energy deposition near irradiated heavy atom nanoparticles, Sci. Rep, vol.1, p.18, 2011.

S. Rosa, C. Connolly, G. Schettino, K. T. Butterworth, and K. M. Prise, Biological mechanisms of gold nanoparticle radiosensitization, Cancer Nanotechnol, vol.8, issue.2, 2017.

K. T. Butterworth, S. J. Mcmahon, F. J. Currell, and K. M. Prise, Physical basis and biological mechanisms of gold nanoparticle radiosensitization, Nanoscale, vol.4, pp.4830-4838, 2012.

J. F. Hainfeld, F. A. Dilmanian, D. N. Slatkin, and H. M. Smilowitz, Radiotherapy enhancement with gold nanoparticles, J. Pharm. Pharmacol, vol.60, pp.977-985, 2008.

P. Retif, Nanoparticles for Radiation Therapy Enhancement: the Key Parameters, Theranostics, vol.5, pp.1030-1044, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01174788

D. P. Dearnaley, Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial, Lancet Lond. Engl, vol.353, pp.267-272, 1999.

S. A. Bhide and C. M. Nutting, Advances in radiotherapy for head and neck cancer, Oral Oncol, vol.46, pp.439-441, 2010.

J. Staffurth, . Radiotherapy-development, and . Board, A review of the clinical evidence for intensity-modulated radiotherapy, Clin. Oncol. R. Coll. Radiol. G. B, vol.22, pp.643-657, 2010.

C. M. Nutting, Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial, Lancet Oncol, vol.12, pp.127-136, 2011.

A. C. Tree, E. J. Alexander, N. J. Van-as, D. P. Dearnaley, and V. Khoo, Biological dose escalation and hypofractionation: what is there to be gained and how will it best be done?, Clin. Oncol. R. Coll. Radiol. G. B, vol.25, pp.483-498, 2013.

F. Vilotte, Post-Prostatectomy Image-Guided Radiotherapy: The Invisible Target Concept, Front. Oncol, vol.7, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01502241

I. J. Chetty, Technology for Innovation in Radiation Oncology, Int. J. Radiat

, Oncol. Biol. Phys, vol.93, pp.485-492, 2015.

L. Kollar and R. Rengan, Stereotactic body radiotherapy, Semin. Oncol, vol.41, pp.776-789, 2014.

J. Cosset, F. Mornex, and F. Eschwège, Hypofractionnement en radiothérapie : l'éternel retour, Cancer/Radiothérapie, vol.17, pp.355-362, 2013.

J. F. Fowler, The linear-quadratic formula and progress in fractionated radiotherapy

, J. Radiol, vol.62, pp.679-694, 1989.

M. C. Joiner, A. Kogel, and . Van-der, Basic Clinical Radiobiology Fourth Edition, 2009.

J. M. Brown, D. J. Carlson, and D. J. Brenner, The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?, Int. J. Radiat. Oncol. Biol. Phys, vol.88, pp.254-262, 2014.

C. Dupin, F. Vilotte, P. Lagarde, A. Petit, and C. Breton-callu, Practice evolution of hypofractionation in breast radiation therapy and medical impact

, Cancer Radiother. J. Soc. Francaise Radiother. Oncol, vol.20, pp.299-303, 2016.

B. Baujat, Hyperfractionated or accelerated radiotherapy for head and neck cancer

J. Bourhis, Status of accelerated fractionation radiotherapy in head and neck squamous cell carcinomas, Cochrane Database Syst. Rev, vol.9, pp.262-266, 1997.

J. Bourhis, Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis, Lancet Lond. Engl, vol.368, pp.843-854, 2006.

T. F. Delaney, Proton therapy in the clinic, Front. Radiat. Ther. Oncol, vol.43, pp.465-485, 2011.

A. M. Allen, An evidence based review of proton beam therapy: the report of ASTRO's emerging technology committee, Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol, vol.103, pp.8-11, 2012.

V. Favaudon, C. Fouillade, and M. Vozenin,

, Cancer Radiother. J. Soc. Francaise Radiother

, Oncol, vol.19, pp.526-531, 2015.

V. Favaudon, Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice, Sci. Transl. Med, vol.6, pp.245-93, 2014.

K. J. Harrington and P. Montay-gruel, Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with dose rates above 100Gy/s, Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol, vol.124, pp.365-369, 2017.

M. Vozenin, The advantage of Flash radiotherapy confirmed in mini-pig and cat-cancer patients, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01812514

N. Magné, C. Chargari, J. Soria, and E. Deutsch, Concomitant chemo-radiotherapy in clinical trials: to promote step by step rational development, Crit. Rev. Oncol. Hematol, vol.70, pp.206-215, 2009.

C. N. Coleman and J. B. Mitchell, Clinical radiosensitization: why it does and does not work, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.17, pp.1-3, 1999.

E. E. Vokes, D. M. Brizel, T. S. Lawrence, and . Concomitant-chemoradiotherapy, J. Clin

, Oncol, vol.25, pp.4031-4032, 2007.

G. G. Steel and M. J. Peckham, Exploitable mechanisms in combined radiotherapychemotherapy: the concept of additivity, Int. J. Radiat. Oncol. Biol. Phys, vol.5, pp.85-91, 1979.

G. G. Steel, Terminology in the description of drug-radiation interactions, Int. J. Radiat

, Oncol. Biol. Phys, vol.5, pp.1145-1150, 1979.

T. Y. Seiwert, J. K. Salama, and E. E. Vokes, The concurrent chemoradiation paradigm--general principles, Nat. Clin. Pract. Oncol, vol.4, pp.86-100, 2007.

C. Chargari, J. Soria, and E. Deutsch, Controversies and challenges regarding the impact of radiation therapy on survival, Ann. Oncol. Off. J. Eur. Soc. Med. Oncol, vol.24, pp.38-46, 2013.

T. S. Lawrence, B. G. Haffty, and J. R. Harris, Milestones in the use of combinedmodality radiation therapy and chemotherapy, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.32, pp.1173-1179, 2014.

J. A. Bonner, Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival, Lancet Oncol, vol.11, pp.21-28, 2010.

S. M. Hiniker, D. S. Chen, and S. J. Knox, Abscopal effect in a patient with melanoma

, N. Engl. J. Med, vol.366, pp.2035-2036, 2012.

M. A. Postow, Immunologic correlates of the abscopal effect in a patient with melanoma, N. Engl. J. Med, vol.366, pp.925-931, 2012.

D. Antoni, S. Bockel, E. Deutsch, and F. Mornex,

, Cancer Radiother. J. Soc. Francaise Radiother. Oncol, vol.20, pp.434-441, 2016.

R. Alonzi, Functional Radiotherapy Targeting using Focused Dose Escalation, Clin

, Oncol. R. Coll. Radiol. G. B, vol.27, pp.601-617, 2015.

P. E. Wallner, Current status and recommendations for the future of research, teaching, and testing in the biological sciences of radiation oncology: report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, executive summary, Int. J. Radiat. Oncol. Biol. Phys, vol.88, pp.11-17, 2014.

D. Thorwarth, Functional imaging for radiotherapy treatment planning: current status and future directions-a review, Br. J. Radiol, vol.88, p.20150056, 2015.

I. S. Chan and G. S. Ginsburg, Personalized medicine: progress and promise, Annu. Rev. Genomics Hum. Genet, vol.12, pp.217-244, 2011.

D. E. Hallahan and M. L. Freeman, Thoughts on the future of research, teaching, and testing in the biological sciences of radiation oncology, Int. J. Radiat. Oncol. Biol. Phys, vol.88, pp.1-2, 2014.

M. Krause and S. Supiot, Advances in radiotherapy special feature, Br. J. Radiol, vol.88, p.20150412, 2015.

C. Buzea, I. I. Pacheco, and K. Robbie, Nanomaterials and nanoparticles: sources and toxicity, Biointerphases, vol.2, pp.17-71, 2007.

S. Singh and H. S. Nalwa, Nanotechnology and health safety--toxicity and risk assessments of nanostructured materials on human health, J. Nanosci. Nanotechnol, vol.7, pp.3048-3070, 2007.

, Nano. Available, vol.101, p.14, 2017.

A. B. Djuri?i?, Toxicity of metal oxide nanoparticles: mechanisms, characterization, and avoiding experimental artefacts, Small Weinh. Bergstr. Ger, vol.11, pp.26-44, 2015.

A. Nel, T. Xia, L. Mädler, and N. Li, Toxic potential of materials at the nanolevel, Science, vol.311, pp.622-627, 2006.

H. F. Krug and P. Wick, Nanotoxicology: an interdisciplinary challenge, Angew. Chem. Int. Ed Engl, vol.50, pp.1260-1278, 2011.

R. Duncan and R. Gaspar, Nanomedicine(s) under the microscope, Mol. Pharm, vol.8, pp.2101-2141, 2011.

M. L. Etheridge, THE BIG PICTURE ON SMALL MEDICINE: THE STATE OF NANOMEDICINE PRODUCTS APPROVED FOR USE OR IN CLINICAL TRIALS, Nanomedicine Nanotechnol. Biol. Med, vol.9, pp.1-14, 2013.

V. Weissig, T. K. Pettinger, and N. Murdock, Nanopharmaceuticals (part 1): products on the market, Int. J. Nanomedicine, vol.9, pp.4357-4373, 2014.

C. Loo, Nanoshell-enabled photonics-based imaging and therapy of cancer

, Technol. Cancer Res. Treat, vol.3, pp.33-40, 2004.

, This is nanotechnology -one of the fastest growing markets in the world, p.2, 2018.

E. H. Chang, Nanomedicine: Past, present and future -A global perspective

, Biochem. Biophys. Res. Commun, vol.468, pp.511-517, 2015.

R. Langer, R. Weissleder, and . Nanotechnology, JAMA, vol.313, pp.135-136, 2015.

M. Ferrari, Cancer nanotechnology: opportunities and challenges, Nat. Rev. Cancer, vol.5, pp.161-171, 2005.

S. Revannasiddaiah and S. P. Susheela, Chemically enhanced radiotherapy: visions for the future, Ann. Transl. Med, vol.4, p.52, 2016.

T. Lammers, L. Y. Rizzo, G. Storm, F. Kiessling, . Personalized-nanomedicine et al.,

, Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.18, pp.4889-4894, 2012.

V. Sanna, N. Pala, and M. Sechi, Targeted therapy using nanotechnology: focus on cancer, Int. J. Nanomedicine, vol.9, pp.467-483, 2014.

J. Shi, P. W. Kantoff, R. Wooster, and O. C. Farokhzad, Cancer nanomedicine: progress, challenges and opportunities, Nat. Rev. Cancer, vol.17, pp.20-37, 2017.

M. Ferrari, M. A. Philibert, and W. R. Sanhai, Nanomedicine and society, Clin. Pharmacol. Ther, vol.85, pp.466-467, 2009.

V. De-matteis and R. Rinaldi, Toxicity Assessment in the Nanoparticle Era, Adv. Exp

, Med. Biol, vol.1048, pp.1-19, 2018.

D. S. Abou, J. E. Pickett, and D. L. Thorek, Nuclear molecular imaging with nanoparticles: radiochemistry, applications and translation, Br. J. Radiol, vol.88, p.20150185, 2015.

A. Z. Wang, R. Langer, and O. C. Farokhzad, Nanoparticle delivery of cancer drugs

, Annu. Rev. Med, vol.63, pp.185-198, 2012.

D. Bobo, K. J. Robinson, J. Islam, K. J. Thurecht, and S. R. Corrie, Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date, Pharm. Res, vol.33, pp.2373-2387, 2016.

S. Akhter, Nanomedicines as cancer therapeutics: current status, Curr. Cancer Drug Targets, vol.13, pp.362-378, 2013.

S. Akhter, Nanomedicines as cancer therapeutics: current status, Curr. Cancer Drug Targets, vol.13, pp.362-378, 2013.

H. Louro, Relevance of Physicochemical Characterization of Nanomaterials for Understanding Nano-cellular Interactions, Adv. Exp. Med. Biol, vol.1048, pp.123-142, 2018.

G. Oberdörster, Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology, J. Intern. Med, vol.267, pp.89-105, 2010.

M. Yu and J. Zheng, Clearance Pathways and Tumor Targeting of Imaging Nanoparticles, ACS Nano, vol.9, pp.6655-6674, 2015.

R. K. Jain and T. Stylianopoulos, Delivering nanomedicine to solid tumors, Nat. Rev. Clin. Oncol, vol.7, pp.653-664, 2010.

J. L. Au, .. Yeung, B. Z. Wientjes, M. G. Lu, Z. Wientjes et al., Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities, Adv. Drug Deliv. Rev, vol.97, pp.280-301, 2016.

Y. Li, J. Wang, M. G. Wientjes, and J. L. Au, Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor, Adv. Drug Deliv. Rev, vol.64, pp.29-39, 2012.

A. I. Minchinton and I. F. Tannock, Drug penetration in solid tumours, Nat. Rev. Cancer, vol.6, pp.583-592, 2006.

J. Schuemann, Roadmap to Clinical Use of Gold Nanoparticles for Radiation Sensitization, Int. J. Radiat. Oncol. Biol. Phys, vol.94, pp.189-205, 2016.

A. Wicki, D. Witzigmann, V. Balasubramanian, and J. Huwyler, Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications, J. Control. Release Off. J. Control. Release Soc, vol.200, pp.138-157, 2015.

L. A. Kunz-schughart, Nanoparticles for radiooncology: Mission, vision, challenges, Biomaterials, vol.120, pp.155-184, 2017.

T. L. Doane and C. Burda, The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy, Chem. Soc. Rev, vol.41, pp.2885-2911, 2012.

S. C. Baetke, T. Lammers, and F. Kiessling, Applications of nanoparticles for diagnosis and therapy of cancer, Br. J. Radiol, vol.88, p.20150207, 2015.

S. M. Ahsan, C. M. Rao, and M. F. Ahmad, Nanoparticle-Protein Interaction: The Significance and Role of Protein Corona, Adv. Exp. Med. Biol, vol.1048, pp.175-198, 2018.

S. K. Hobbs, Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment, Proc. Natl. Acad. Sci. U. S. A, vol.95, pp.4607-4612, 1998.

K. Greish, Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines, J. Drug Target, vol.15, pp.457-464, 2007.

H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori, Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review, J. Control. Release Off. J. Control. Release Soc, vol.65, pp.271-284, 2000.

A. D. Wong, M. Ye, M. B. Ulmschneider, and P. Searson, Quantitative Analysis of the Enhanced Permeation and Retention (EPR) Effect, PloS One, vol.10, p.123461, 2015.

S. Kunjachan, J. Ehling, G. Storm, F. Kiessling, and T. Lammers, Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects, Chem. Rev, vol.115, pp.10907-10937, 2015.

S. M. Miller and A. Z. Wang, Nanomedicine in chemoradiation. Ther. Deliv, vol.4, pp.239-250, 2013.

D. K. Chatterjee, P. Diagaradjane, and S. Krishnan, Nanoparticle-mediated hyperthermia in cancer therapy, Ther. Deliv, vol.2, pp.1001-1014, 2011.

V. Weissig and D. Guzman-villanueva, Nanopharmaceuticals (part 2): products in the pipeline, Int. J. Nanomedicine, vol.10, pp.1245-1257, 2015.

G. Luo, Quantum dots in cancer therapy, Expert Opin. Drug Deliv, vol.9, pp.47-58, 2012.

T. Q. Le, H. Seznec, and M. Delville, Functionalized nanomaterials: their use as contrast agents in bioimaging: mono-and multimodal approaches, Nanotechnol. Rev, vol.2, pp.125-169, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00814288

M. G. Harisinghani, Noninvasive detection of clinically occult lymph-node metastases in prostate cancer, N. Engl. J. Med, vol.348, pp.2491-2499, 2003.

A. S. Fortuin, R. J. Smeenk, H. J. Meijer, A. J. Witjes, and J. O. Barentsz, Lymphotropic nanoparticle-enhanced MRI in prostate cancer: value and therapeutic potential, Curr. Urol. Rep, vol.15, p.389, 2014.

C. S. Thaxton, Nanoparticle-based bio-barcode assay redefines 'undetectable' PSA and biochemical recurrence after radical prostatectomy, Proc. Natl. Acad. Sci. U. S. A, vol.106, pp.18437-18442, 2009.

F. W. Spiers, The influence of energy absorption and electron range on dosage in irradiated bone, Br. J. Radiol, vol.22, pp.521-533, 1949.

J. F. Hainfeld, D. N. Slatkin, and H. M. Smilowitz, The use of gold nanoparticles to enhance radiotherapy in mice, Phys. Med. Biol, vol.49, pp.309-315, 2004.

F. H. Adams, A. Norman, R. S. Mello, and D. Bass, Effect of radiation and contrast media on chromosomes, Radiology, vol.124, pp.823-826, 1977.

H. Matsudaira, A. M. Ueno, and I. Furuno, Iodine contrast medium sensitizes cultured mammalian cells to X rays but not to gamma rays, Radiat. Res, vol.84, pp.144-148, 1980.

D. M. Herold, I. J. Das, C. C. Stobbe, R. V. Iyer, and J. D. Chapman, Gold microspheres: a selective technique for producing biologically effective dose enhancement, Int. J. Radiat. Biol, vol.76, pp.1357-1364, 2000.

K. M. Prise and S. G. Martin, Editorial-nanoparticles for diagnostic imaging and radiotherapy, Br. J. Radiol, vol.88, p.20150692, 2015.

L. Strigari, Targeted dose enhancement in radiotherapy for breast cancer using gold nanoparticles, part 2: A treatment planning study, Med. Phys, vol.44, 1993.

S. Lacombe, E. Porcel, and E. Scifoni, Particle therapy and nanomedicine: state of art and research perspectives, Cancer Nanotechnol, vol.8, p.9, 2017.

A. Pottier, E. Borghi, and L. Levy, The future of nanosized radiation enhancers, Br. J. Radiol, vol.88, p.20150171, 2015.

J. Marill, Hafnium oxide nanoparticles: toward an in vitro predictive biological effect?, Radiat. Oncol. Lond. Engl, vol.9, p.150, 2014.

J. A. Coulter, K. T. Butterworth, and S. Jain, Prostate cancer radiotherapy: potential applications of metal nanoparticles for imaging and therapy, Br. J. Radiol, vol.88, p.20150256, 2015.

J. C. Roeske, L. Nunez, M. Hoggarth, E. Labay, and R. R. Weichselbaum, Characterization of the theorectical radiation dose enhancement from nanoparticles, Technol. Cancer Res. Treat, vol.6, pp.395-401, 2007.

S. W. Botchway, J. A. Coulter, and F. J. Currell, Imaging intracellular and systemic in vivo gold nanoparticles to enhance radiotherapy, Br. J. Radiol, vol.88, p.20150170, 2015.

Y. Liu, Metal-basedNanoEnhancersfor Future Radiotherapy: Radiosensitizing and Synergistic Effects on Tumor Cells, Theranostics, vol.8, pp.1824-1849, 2018.

M. Babaei and M. Ganjalikhani, The potential effectiveness of nanoparticles as radio sensitizers for radiotherapy, BioImpacts BI, vol.4, pp.15-20, 2014.

C. Mirjolet, The radiosensitization effect of titanate nanotubes as a new tool in radiation therapy for glioblastoma: a proof-of-concept, Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol, vol.108, pp.136-142, 2013.

L. Maggiorella, Nanoscale radiotherapy with hafnium oxide nanoparticles, Future Oncol. Lond. Engl, vol.8, pp.1167-1181, 2012.

S. J. Mcmahon, Nanodosimetric effects of gold nanoparticles in megavoltage radiation therapy, Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol, vol.100, pp.412-416, 2011.

S. J. Mcmahon, K. M. Prise, and F. J. Currell, Comment on 'implications on clinical scenario of gold nanoparticle radiosensitization in regard to photon energy, nanoparticle size, concentration and location, Phys. Med. Biol, vol.57, pp.287-290, 2012.

M. Yamada, M. Foote, and T. W. Prow, Therapeutic gold, silver, and platinum nanoparticles, Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol, vol.7, pp.428-445, 2015.

E. Lechtman, Implications on clinical scenario of gold nanoparticle radiosensitization in regards to photon energy, nanoparticle size, concentration and location, Phys. Med. Biol, vol.56, pp.4631-4647, 2011.

S. Wilhelm, Analysis of nanoparticle delivery to tumours, Nat. Rev. Mater, vol.1, p.16014, 2016.

S. Jain, Cell-specific radiosensitization by gold nanoparticles at megavoltage radiation energies, Int. J. Radiat. Oncol. Biol. Phys, vol.79, pp.531-539, 2011.

J. A. Coulter, W. B. Hyland, J. Nicol, and F. J. Currell, Radiosensitising nanoparticles as novel cancer therapeutics--pipe dream or realistic prospect?, Clin. Oncol. R. Coll. Radiol. G. B, vol.25, pp.593-603, 2013.

D. B. Chithrani, Gold nanoparticles as radiation sensitizers in cancer therapy, Radiat. Res, vol.173, pp.719-728, 2010.

V. Ferrero, Targeted dose enhancement in radiotherapy for breast cancer using gold nanoparticles, part 1: A radiobiological model study, Med. Phys, vol.44, 1983.

K. Ando and D. T. Goodhead, Dependence and independence of survival parameters on linear energy transfer in cells and tissues, J. Radiat. Res. (Tokyo), vol.57, pp.596-606, 2016.

T. Paunesku, S. Gutiontov, K. Brown, and G. E. Woloschak, Radiosensitization and nanoparticles, Cancer Treat. Res, vol.166, pp.151-171, 2015.

S. J. Mcmahon, H. Paganetti, and K. M. Prise, Optimising element choice for nanoparticle radiosensitisers, Nanoscale, vol.8, pp.581-589, 2016.

C. Hwang, J. M. Kim, and J. Kim, Influence of concentration, nanoparticle size, beam energy, and material on dose enhancement in radiation therapy, J. Radiat. Res. (Tokyo), vol.58, pp.405-411, 2017.

J. M. Brown and F. J. Currell, A local effect model-based interpolation framework for experimental nanoparticle radiosensitisation data, Cancer Nanotechnol, vol.8, p.1, 2017.

S. Incerti, M. Douglass, S. Penfold, S. Guatelli, and E. Bezak, Review of Geant4-DNA applications for micro and nanoscale simulations, Phys. Medica PM Int. J. Devoted Appl. Phys. Med. Biol. Off. J. Ital. Assoc. Biomed. Phys. AIFB, vol.32, pp.1187-1200, 2016.

L. Trequesser and Q. , Single cell in situ detection and quantification of metal oxide nanoparticles using multimodal correlative microscopy, Anal. Chem, vol.86, pp.7311-7319, 2014.
URL : https://hal.archives-ouvertes.fr/in2p3-01072989

P. Barberet, Monte-Carlo dosimetry on a realistic cell monolayer geometry exposed to alpha particles, Phys. Med. Biol, vol.57, pp.2189-2207, 2012.
URL : https://hal.archives-ouvertes.fr/in2p3-00695637

L. Sancey, The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy, Br. J. Radiol, vol.87, p.20140134, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01053790

E. Lechtman and J. Pignol, Interplay between the gold nanoparticle sub-cellular localization, size, and the photon energy for radiosensitization, Sci. Rep, vol.7, p.13268, 2017.

A. L. Mcnamara, Dose enhancement effects to the nucleus and mitochondria from gold nanoparticles in the cytosol, Phys. Med. Biol, vol.61, pp.5993-6010, 2016.

M. Zuberek and A. Grzelak, Nanoparticles-Caused Oxidative Imbalance, Adv. Exp. Med. Biol, vol.1048, pp.85-98, 2018.

N. N. Cheng, Chemical enhancement by nanomaterials under X-ray irradiation, J. Am. Chem. Soc, vol.134, pp.1950-1953, 2012.

M. Simon, In situ quantification of diverse titanium dioxide nanoparticles unveils selective endoplasmic reticulum stress-dependent toxicity, Nanotoxicology, vol.11, pp.134-145, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01447226

M. Garlatti and R. Barouki, Le stress du réticulum endoplasmique : adaptation et toxicité. MS Médecine Sci, vol.18, pp.585-594, 2002.

M. Simon, P. Barberet, M. Delville, P. Moretto, and H. Seznec, Titanium dioxide nanoparticles induced intracellular calcium homeostasis modification in primary human keratinocytes. Towards an in vitro explanation of titanium dioxide nanoparticles toxicity, Nanotoxicology, vol.5, pp.125-139, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00598703

W. Roa, Gold nanoparticle sensitize radiotherapy of prostate cancer cells by regulation of the cell cycle, Nanotechnology, vol.20, p.375101, 2009.

J. Wolfram, Safety of Nanoparticles in Medicine, Curr. Drug Targets, vol.16, pp.1671-1681, 2015.

J. Sengupta, S. Ghosh, P. Datta, A. Gomes, and A. Gomes, Physiologically important metal nanoparticles and their toxicity, J. Nanosci. Nanotechnol, vol.14, pp.990-1006, 2014.

R. Gaspar and R. Duncan, Polymeric carriers: preclinical safety and the regulatory implications for design and development of polymer therapeutics, Adv. Drug Deliv. Rev, vol.61, pp.1220-1231, 2009.

K. Donaldson, V. Stone, C. L. Tran, W. Kreyling, and P. J. Borm, Nanotoxicology. Occup. Environ. Med, vol.61, pp.727-728, 2004.

H. M. Kipen and D. L. Laskin, Smaller is not always better: nanotechnology yields nanotoxicology, Am. J. Physiol. Lung Cell. Mol. Physiol, vol.289, pp.696-697, 2005.

V. Stone and K. Donaldson, Nanotoxicology: signs of stress, Nat. Nanotechnol, vol.1, pp.23-24, 2006.

S. A. Love, M. A. Maurer-jones, J. W. Thompson, Y. Lin, and C. L. Haynes, Assessing nanoparticle toxicity, Annu. Rev. Anal. Chem. Palo Alto Calif, vol.5, pp.181-205, 2012.

S. Dwivedi, Toxicogenomics: A New Paradigm for Nanotoxicity Evaluation, Adv. Exp. Med. Biol, vol.1048, pp.143-161, 2018.

M. Umair, Nanotoxicity of Inert Materials: The Case of Gold, Silver and Iron, J. Pharm. Pharm. Sci. Publ. Can. Soc. Pharm. Sci. Soc. Can. Sci. Pharm, vol.19, pp.161-180, 2016.

S. Sabella, A general mechanism for intracellular toxicity of metal-containing nanoparticles, Nanoscale, vol.6, pp.7052-7061, 2014.

C. Meindl, T. Kueznik, M. Bösch, E. Roblegg, and E. Fröhlich, Intracellular calcium levels as screening tool for nanoparticle toxicity, J. Appl. Toxicol. JAT, vol.35, pp.1150-1159, 2015.

K. Girigoswami, Toxicity of Metal Oxide Nanoparticles, Adv. Exp. Med. Biol, vol.1048, pp.99-122, 2018.

S. Bettini, Food-grade TiO2impairs intestinal and systemic immune homeostasis, initiates preneoplastic lesions and promotes aberrant crypt development in the rat colon, Sci. Rep, vol.7, p.40373, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01508951

R. K. Gherardi and F. J. Authier, Macrophagic myofasciitis: characterization and pathophysiology, Lupus, vol.21, pp.184-189, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00665883

L. J. Jara, Severe manifestations of autoimmune syndrome induced by adjuvants (Shoenfeld's syndrome), Immunol. Res, vol.65, pp.8-16, 2017.

, What happened to personalized medicine?, Nat. Biotechnol, vol.30, p.1, 2012.

M. Hofmann-amtenbrink, D. W. Grainger, and H. Hofmann, Nanoparticles in medicine: Current challenges facing inorganic nanoparticle toxicity assessments and standardizations, Nanomedicine Nanotechnol. Biol. Med, vol.11, pp.1689-1694, 2015.

A. Wicki, D. Witzigmann, V. Balasubramanian, and J. Huwyler, Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications, J. Control. Release Off. J. Control. Release Soc, vol.200, pp.138-157, 2015.

M. G. Wacker, A. Proykova, and G. M. Santos, Dealing with nanosafety around the globe-Regulation vs. innovation, Int. J. Pharm, vol.509, pp.95-106, 2016.

A. D. Maynard, Don't define nanomaterials, Nature, vol.475, p.31, 2011.

P. Zygmanski and E. Sajo, Nanoscale radiation transport and clinical beam modeling for gold nanoparticle dose enhanced radiotherapy (GNPT) using X-rays, Br. J. Radiol, vol.89, p.20150200, 2016.

K. Maier-hauff, Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme, J. Neurooncol, vol.81, pp.53-60, 2007.

T. Nanoxray and . Nanobiotix,

S. Bonvalot, First-in-Human Study Testing a New Radioenhancer Using Nanoparticles (NBTXR3) Activated by Radiation Therapy in Patients with Locally Advanced Soft Tissue Sarcomas, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.23, pp.908-917, 2017.

, NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating and Randomized Patients in Two Arms With Soft Tissue Sarcoma of the Extremity and Trunk Wall -Full Text View -ClinicalTrials.gov. Available at, p.30, 2018.

, Available at, NANOBIOTIX. NANOBIOTIX annonce les résultats positifs de sa phase II/III dans les sarcomes des tissus mous avec NBTXR3, p.22, 2018.

S. Bonvalot, LBA66A phase II/III trial of hafnium oxide nanoparticles activated by radiotherapy in the treatment of locally advance soft tissue sarcoma of the extremity and trunk wall, Ann. Oncol, vol.29, 2018.

, NBTXR3 Crystalline Nanoparticles and Stereotactic Body Radiation Therapy in the Treatment of Liver Cancers -Full Text View -ClinicalTrials.gov. Available at, p.30, 2018.

, NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Patients With Locally Advanced Squamous Cell Carcinoma of the Oral Cavity or Oropharynx -Full Text View -ClinicalTrials, p.30, 2018.

, A Study of PEP503 With Radiotherapy in Combination With Concurrent Chemotherapy for Patients With Head and Neck Cancer -Full Text View -ClinicalTrials, p.23, 2018.

, NBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate Adenocarcinoma -Full Text View -ClinicalTrials.gov. Available at, p.30, 2018.

, NBTXR3 Activated by SABR for Patients With Advanced HNSCC or NSCLC Treated With an Anti-PD1 Antibody -Full Text View -ClinicalTrials.gov. Available at, p.23, 2018.

, A Study of PEP503(Radio-enhancer) With Radiotherapy and Chemotherapy for Patients With Rectal Cancer -Full Text View -ClinicalTrials, p.24, 2018.

F. Lux,

, Cancer Radiother. J. Soc. Francaise Radiother. Oncol, vol.19, pp.508-514, 2015.

, Radiosensitization of Multiple Brain Metastases Using AGuIX Gadolinium Based Nanoparticles -Full Text View -ClinicalTrials.gov. Available at, p.28, 2018.

, AGuIX Gadolinium-based Nanoparticles in Combination With Chemoradiation and Brachytherapy -Full Text View -ClinicalTrials.gov. Available at, p.30, 2018.

M. Simon, P. Barberet, M. Delville, P. Moretto, and H. Seznec, Titanium dioxide nanoparticles induced intracellular calcium homeostasis modification in primary human keratinocytes. Towards an in vitro explanation of titanium dioxide nanoparticles toxicity, Nanotoxicology, vol.5, pp.125-139, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00598703

P. Barberet and H. Seznec, Advances in microbeam technologies and applications to radiation biology, Radiat. Prot. Dosimetry, vol.166, pp.182-187, 2015.

S. Bourret, Fluorescence time-lapse imaging of single cells targeted with a focused scanning charged-particle microbeam, Nucl. Instrum. Methods Phys. Res. Sect. B Beam Interact. Mater. At, vol.325, pp.27-34, 2014.
URL : https://hal.archives-ouvertes.fr/in2p3-00956455

G. Muggiolu, Single ?-particle irradiation permits real-time visualization of RNF8 accumulation at DNA damaged sites, Sci. Rep, vol.7, p.41764, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01763042

S. Incerti, Monte Carlo dosimetry for targeted irradiation of individual cells using a microbeam facility, Radiat. Prot. Dosimetry, vol.133, pp.2-11, 2009.
URL : https://hal.archives-ouvertes.fr/in2p3-00373963

, Titanium Dioxide Nanoparticles (Tio2 Nanoparticles) | Knowledge Base Nanomaterials, 2018.

T. Zeman, E. Loh, D. ?ierný, and O. ?erý, Penetration, distribution and brain toxicity of titanium nanoparticles in rodents' body: a review, IET Nanobiotechnol, vol.12, pp.695-700, 2018.

B. Zhang, ER stress induced by ionising radiation in IEC-6 cells, Int. J. Radiat. Biol, vol.86, pp.429-435, 2010.

T. Yamamori, S. Meike, M. Nagane, H. Yasui, and O. Inanami, ER stress suppresses DNA double-strand break repair and sensitizes tumor cells to ionizing radiation by stimulating proteasomal degradation of Rad51, FEBS Lett, vol.587, pp.3348-3353, 2013.

C. Hetz and E. Chevet, Theme Series--UPR in cancer, Semin. Cancer Biol, vol.33, pp.1-2, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01151623

, Serment d'Hippocrate

, éléments, physiques et mentaux, individuels et sociaux

, Je respecterai toutes les personnes, leur autonomie et leur volonté, sans aucune discrimination selon leur état ou leurs convictions. J'interviendrai pour les protéger si elles sont affaiblies, vulnérables ou menacées dans leur intégrité ou leur dignité. Même sous la contrainte

, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité

, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses

, que je sois déshonoré et méprisé si j'y manque